Sec. 3056. INSTITUTIONAL REVIEW BOARD FLEXIBILITY
135 words·~1 min read·
/statute-compilations/comps-13005/sec-3056A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 3056 INSTITUTIONAL REVIEW BOARD FLEXIBILITY Section 520 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360j) is amended— ####
(1)in subsection (g)(3)— #####
(A)in subparagraph (A)(i)— ######
(i)by striking “local”; and ######
(ii)by striking “which has been”; and #####
(B)in subparagraph (B), by striking “a local institutional” and inserting “an institutional”; and ####
(2)in subsection (m)(4)— #####
(A)by striking subparagraph
(A)and inserting the following: > > ##### “(A) > > in facilities in which clinical testing of devices is supervised by an institutional review committee established in accordance with the regulations of the Secretary; and” > ; #####
(B)in subparagraph (B), by striking “a local institutional” and inserting “an institutional”; and #####
(C)in the matter following subparagraph (B), by striking “local”.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 3056
INSTITUTIONAL REVIEW BOARD FLEXIBILITY
Cites 1Cited by 0 across 0 sources